Expression profile of ADAM10 and ADAM17 in allergic rhinitis

Hee Won Chueh1, Seong Kook Park2, Dae Young Hur3

  • 1Department of Pediatrics, Dong-A University, College of Medicine, Busan, Korea.

Abstract

Insights

Researchers found decreased ADAM17 and increased ADAM10 expression in allergic rhinitis nasal tissue. This study investigated the roles of ADAM10 and ADAM17 in allergic rhinitis development.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • A disintegrin and metalloprotease (ADAM) gene family plays roles in extracellular matrix homeostasis, signal transduction, and cell migration.
  • ADAM17 is a well-characterized sheddase with numerous substrates involved in inflammation.
  • ADAM10 shares structural and sequence similarities with ADAM17, suggesting potential overlapping functions.

Purpose of the Study:

  • To investigate the expression levels of ADAM10 and ADAM17 in the nasal mucosa of individuals with allergic rhinitis.
  • To elucidate the potential roles of ADAM10 and ADAM17 in the pathogenesis of allergic rhinitis.

Main Methods:

  • Expression analysis of ADAM10 and ADAM17 in allergic and non-allergic nasal mucosa samples.
  • Utilized reverse-transcription polymerase chain reaction (RT-PCR) for mRNA level assessment.
  • Employed Western blotting and densitometry for quantitative protein level analysis.

Main Results:

  • ADAM17 mRNA and protein levels were significantly lower in allergic nasal mucosa compared to non-allergic controls.
  • ADAM10 mRNA and protein levels were significantly lower in non-allergic nasal mucosa compared to allergic samples.
  • Demonstrated differential expression patterns for ADAM10 and ADAM17 in allergic rhinitis.

Conclusions:

  • Reduced ADAM17 expression and increased ADAM10 expression may be implicated in allergic rhinitis development via unidentified mechanisms.
  • Understanding the distinct expression profiles of ADAM10 and ADAM17 is crucial for deciphering allergic rhinitis mechanisms.
  • Further research is warranted to explore the specific pathways influenced by these ADAM proteases in allergic inflammation.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
33.7K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K